Andy Scharenberg is the founder of Umoja Biopharma. Umoja Biopharma has raised $153M in total funding. Latest round: Series C.
Andy Scharenberg, M.D., is the Co-Founder and CEO of Umoja Biopharma, a Seattle-based biotech company founded in 2019 that develops in-body CAR-T cell therapies for cancer and autoimmunity. He leads the company's advancement of programs through early clinical testing for blood cancer and pediatric osteogenic sarcoma.
Full founder directory · Investor directory · Company funding database · Fundraising library